Plasma albumin and platelet function: Relevance to atherogenesis and thrombosis

Platelets

Volumn 7, Issue 3, 1996, Pages 125-137

  Mikhailidis, D P ^a   Ganotakis, E S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; APYRASE; ARACHIDONIC ACID; BEZAFIBRATE; BILIRUBIN; CLOFIBRATE; FATTY ACID; FIBRINOGEN; GEMFIBROZIL; ICOSANOID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; SERUM ALBUMIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2;

AGING; ANALBUMINEMIA; ARACHIDONIC ACID METABOLISM; ATHEROGENESIS; DIABETES MELLITUS; ENZYME ACTIVITY; HUMAN; HYPOALBUMINEMIA; ICOSANOID METABOLISM; NEPHROTIC SYNDROME; NONHUMAN; OXYGENATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SMOKING; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS; VASCULAR DISEASE;

EID: 0029789683     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.3109/09537109609023571     Document Type: Review

References (17)

1. 2 formation from thrombin-stimulated human platelets by sequestering the liberated arachidonic acid in the extracellular space. Platelets 1995; 6: 381-7.
2. Al-Mugeirin M M, Gader A M A, Al-Rasheed S A, Bahakim H M, Al-Momen A K, Al-Salloum A. Platelet aggregometry - dose related responses to arachidonic acid in childhood nephrotic syndrome. Platelets 1995; 6: 71-4.
3. Phillips A N, Shaper A G, Whincup P H. Association between serum albumin and mortality from cardiovascular disease, cancer and other causes. Lancet 1989; ii: 1434-6.
4. Kuller L H, Eichner J E, Orchard T J, Grandits G A, McCallum L, Tracy R P. The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol 1991; 134: 1266-77.
5. Purdon A D, Rao A K. Interaction of albumin, arachidonic acid and prostanoids in platelets. Prostagl Leukotr Essntl Fatty Acids: Revs 1989; 35: 213-8.
6. Rao A K, Koike K, Day H J, Smith J B, Holmsen H. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Am J Clin Pathol 1985; 83: 687-96.
7. 2 in platelet activation by endogenous arachidonate. Eicosanoids 1989; 2: 241-8.
8. 2. Biochem Pliarmacol 1984; 33: 2083-8.
9. Guichardant M, Petit F, Lagarde M. Metabolism of endogenous arachidonic acid in weakly activated platelets. Absence of leukocyte cooperative products in whole blood. Eicosanoids 1989; 2: 117-21.
10. Peplow P V, Mikhailidis D P. Platelet activating factor (PAF) and its relation to prostaglandins, leukotrienes and other aspects of arachidonate metabolism. Prostagl Leukotr Essntl Fatty Acids 1990; 41: 71-82.
11. Tokomura A, Yoshida J, Maruyama T, Fukuzawa K, Tsukatani H. Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor. Thromb Res 1987; 46: 51-63.
12. Colli S, Maderna P, Caruso D, Stragliotto E, Galli G, Tremoli E. Albumin interferes with arachidonate metabolism in platelets and neutrophils. Eicosanoids 1989; 2: 51-7.
13. Fitzgerald G A, Brash A R, Oates J A, Pedersen A K. Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man. J Clin Invest 1983; 72: 1336-43.
14. Doweiko J P, Bistrian B R. The effect of glycosylated albumin on platelet aggregation. J Parenteral Enteral Nutrn 1994; 18: 516-20.
15. Surya I I, Gorter G, Akkerman J W. Arachidonate transfer between platelets and lipoproteins. Thromb Haemostas 1992; 68: 719-26.
16. Mikhailidis D P, Mikhailidis A M, Dandona P. Effect of human plasma proteins on stabilisation of platelet anti-aggregatory activity of prostacyclin. Ann Clin Biochem 1982; 19: 241-4.
17. Mikhailidis D P, Mikhailidis A M, Barradas M A, Dandona P. Effect of non-esterified fatty acids on the stability of prostacyclin activity. Metabolism 1983; 32: 717-21.